Gavi allocates $50 million to Bundibugyo ebolavirus vaccine development and outbreak response (gavi.org)

• Up to $40 million for vaccine access and manufacturing scale-up
• $10 million for outbreak response and immunization protection
• Coordinated with CEPI, WHO, Africa CDC, UNICEF

"Gavi, the Vaccine Alliance, has committed up to $50 million from its First Response Fund (FRF) to support the response to the ongoing Bundibugyo ebolavirus outbreak. $40 million will be used to accelerate vaccine access by incentivizing manufacturers to commit to high-capacity production, enabling rapid deployment of investigational doses once clinical trials show positive results. An additional $10 million will support outbreak response, including protecting routine immunization and preparing for future vaccines. Gavi is coordinating with CEPI, WHO, Africa CDC, and UNICEF to design financial mechanisms such as Advance Purchase Commitments."